HIV treatment planning involves choosing antiretroviral medicines that can effectively suppress the virus while supporting long term health and treatment adherence. Healthcare professionals consider viral load, CD4 count, resistance testing, existing health conditions, possible drug interactions, pregnancy considerations, and previous HIV medicine exposure when selecting treatment. Modern antiretroviral therapy often uses combinations containing integrase strand transfer inhibitors because of their effectiveness, tolerability, and resistance profile. Treatment plans are individualized, regularly monitored, and adjusted when necessary. Understanding how medicine selection works can help people with HIV discuss appropriate options, testing, monitoring, and adherence strategies with qualified healthcare professionals.
HIV treatment has changed significantly with the development of effective antiretroviral therapy. The main aim of treatment is to suppress HIV replication, protect the immune system, improve long term health, and help people with HIV maintain a good quality of life. Antiretroviral therapy should be selected and monitored by a qualified healthcare professional because the most appropriate medicines can differ from person to person. Current guidance emphasizes individualized treatment based on medical history, laboratory results, potential interactions, and other personal considerations.
Treatment planning generally begins with an assessment of the person's HIV status and overall health. Healthcare professionals review laboratory tests and medical history before selecting an appropriate antiretroviral regimen. HIV viral load measures the amount of virus in the blood, while the CD4 count provides information about immune system function. Resistance testing can also help identify medicines that may be less effective because of HIV mutations.
Important factors considered during treatment planning include:
For many adults beginning treatment, modern guidelines commonly favor regimens containing an integrase strand transfer inhibitor such as bictegravir or dolutegravir. These medicines are generally highly effective and have favorable tolerability and resistance characteristics. However, the appropriate combination depends on individual circumstances.
Starting antiretroviral therapy is only one part of HIV care. Regular follow-up helps healthcare professionals determine whether treatment is working effectively and whether any changes are needed. Viral load testing is particularly important because sustained viral suppression is a central goal of therapy. Healthcare professionals may also monitor CD4 counts, kidney and liver function, medication tolerability, and possible drug interactions.
People taking HIV treatment can support effective therapy by:
Some people may qualify for particular two-drug or alternative regimens, while others may require combinations that address specific circumstances such as hepatitis B coinfection or potential drug resistance. For example, dolutegravir with lamivudine is not appropriate in certain situations, including some people with high viral loads, hepatitis B coinfection, or when relevant resistance information is unavailable.
HIV treatment decisions should therefore be individualized rather than based on a single medicine or regimen. Reliable information from recognized health authorities and ongoing communication with a qualified healthcare professional can help people understand their options and maintain effective treatment over time.